Multiple Myeloma
Specialized treatment including novel immunotherapies and stem cell transplant support for multiple myeloma.
Overview
Multiple myeloma is a cancer of plasma cells in the bone marrow. Treatment has advanced dramatically in recent years with the introduction of proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and bispecific antibodies.
Our team manages the full continuum of myeloma care — from smoldering myeloma surveillance through frontline treatment, transplant coordination, and management of relapsed disease.
Symptoms & Warning Signs
- Bone pain, especially in the spine or ribs
- Fatigue and weakness
- Frequent infections
- Kidney problems or elevated calcium
- Numbness or tingling in extremities
Diagnosis & Evaluation
Blood & Urine Tests
SPEP, UPEP, free light chains, beta-2 microglobulin
Bone Marrow Biopsy
Plasma cell quantification with FISH cytogenetics
Imaging
PET/CT, whole-body low-dose CT, or MRI for bone lesions
Treatment Options
Frequently Asked Questions
Is myeloma curable?
While myeloma is not yet considered curable for most patients, modern treatments have significantly extended survival. Many patients achieve deep remissions and live for years with good quality of life.
What is a stem cell transplant?
Autologous stem cell transplant uses your own stem cells collected before high-dose chemotherapy, then returned to rebuild your bone marrow. It remains a key treatment for eligible myeloma patients.
